From: Induction strategy with enfuvirtide: results from the Fuziona study, a multicenter retrospective study in Spain
Rebounder n = 4
Non-Rebounder n = 37
Major PI mutations (median)
6
3
DRV or RAL or MVC in the regimen
0 (0%)
7 (19%)
TPV in the regimen
2 (50%)
7 (18,9%)
Total Time on T20 (median, months)
17,8
7